Načítá se...
A Dose Response Study of Thymosin β4 for the Treatment of Acute Stroke
BACKGROUND: Thymosin β4 (Tβ4) is a 5K actin binding peptide. Tβ4 improves neurological outcome in a rat model of embolic stroke and research is now focused on optimizing its dose for clinical trials. The purpose of this study was to perform a dose response study of Tβ4 to determine the optimal dose...
Uloženo v:
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4177939/ https://ncbi.nlm.nih.gov/pubmed/25060418 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jns.2014.07.006 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|